Literature DB >> 31871084

Evaluation of the Activity of a Combination of Three Bacteriophages Alone or in Association with Antibiotics on Staphylococcus aureus Embedded in Biofilm or Internalized in Osteoblasts.

Camille Kolenda1,2,3, Jérôme Josse4,3, Mathieu Medina5, Cindy Fevre5, Sébastien Lustig6,3, Tristan Ferry4,7,3, Frédéric Laurent4,2,3,8.   

Abstract

Staphylococcus aureus is responsible for difficult-to-treat bone and joint infections (BJIs). This is related to its ability to form biofilm and to be internalized and persist inside osteoblasts. Recently, bacteriophage therapy has emerged as a promising option to improve treatment of such infections, but data on its activity against the specific bacterial lifestyles presented above remain scarce. We evaluated the activity of a combination of three bacteriophages, recently used for compassionate treatment in France, against S. aureus HG001 in a model of staphylococcal biofilm and a model of osteoblasts infection, alone or in association with vancomycin or rifampin. The activity of bacteriophages against biofilm-embedded S. aureus was dose dependent. In addition, synergistic effects were observed when bacteriophages were combined with antibiotics used at the lowest concentrations. Phage penetration into osteoblasts was observed only when the cells were infected, suggesting a S. aureus-dependent Trojan horse mechanism for internalization. The intracellular bacterial count of bacteria in infected osteoblasts treated with bacteriophages as well as with vancomycin was significantly higher than in cells treated with lysostaphin, used as a control condition, owing to the absence of intracellular activity and the rapid killing of bacteria released after the death of infected cells. These results suggest that bacteriophages are both inactive in the intracellular compartment after being internalized in infected osteoblasts and present a delayed killing effect on bacteria released after cell lysis into the extracellular compartment, which avoids preventing them from infecting other osteoblasts. The combination of bacteriophages tested was highly active against S. aureus embedded in biofilm but showed no activity against intracellular bacteria in the cell model used.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureus; antibiotic; bacteriophages; biofilm; intracellular; osteoblasts

Year:  2020        PMID: 31871084      PMCID: PMC7038305          DOI: 10.1128/AAC.02231-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages.

Authors:  Sandeep Kaur; Kusum Harjai; Sanjay Chhibber
Journal:  Appl Microbiol Biotechnol       Date:  2014-03-18       Impact factor: 4.813

2.  Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin.

Authors:  Marzia Rahman; Shukho Kim; Sung Min Kim; Sung Yong Seol; Jungmin Kim
Journal:  Biofouling       Date:  2011-11       Impact factor: 3.209

3.  Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates.

Authors:  Silvia Herbert; Anne-Kathrin Ziebandt; Knut Ohlsen; Tina Schäfer; Michael Hecker; Dirk Albrecht; Richard Novick; Friedrich Götz
Journal:  Infect Immun       Date:  2010-03-08       Impact factor: 3.441

Review 4.  Periprosthetic joint infection.

Authors:  Bhaveen H Kapadia; Richard A Berg; Jacqueline A Daley; Jan Fritz; Anil Bhave; Michael A Mont
Journal:  Lancet       Date:  2015-06-28       Impact factor: 79.321

5.  Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes.

Authors:  Tristan Ferry; Thomas Perpoint; François Vandenesch; Jerome Etienne
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

Review 6.  Osteomyelitis.

Authors:  Daniel P Lew; Francis A Waldvogel
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

7.  Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia.

Authors:  Sabrina I Green; Jason T Kaelber; Li Ma; Barbara W Trautner; Robert F Ramig; Anthony W Maresso
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

Review 8.  Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis.

Authors:  Jérôme Josse; Frédéric Velard; Sophie C Gangloff
Journal:  Front Cell Infect Microbiol       Date:  2015-11-26       Impact factor: 5.293

9.  Intracellular Survival of Staphylococcus aureus in Endothelial Cells: A Matter of Growth or Persistence.

Authors:  Guillaume Rollin; Xin Tan; Fabiola Tros; Marion Dupuis; Xavier Nassif; Alain Charbit; Mathieu Coureuil
Journal:  Front Microbiol       Date:  2017-07-19       Impact factor: 5.640

10.  Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against Staphylococcus aureus Biofilms.

Authors:  Dilini Kumaran; Mariam Taha; QiLong Yi; Sandra Ramirez-Arcos; Jean-Simon Diallo; Alberto Carli; Hesham Abdelbary
Journal:  Front Microbiol       Date:  2018-02-05       Impact factor: 5.640

View more
  11 in total

Review 1.  Bacteriophage Therapy in Implant-Related Orthopedic Infections.

Authors:  Madhan Jeyaraman; Naveen Jeyaraman; Vijay Kumar Konkathi; Arulkumar Nallakumarasamy; Sathish Muthu; Manish Khanna
Journal:  Indian J Orthop       Date:  2022-08-26       Impact factor: 1.033

Review 2.  Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies.

Authors:  Jonah Clegg; Elisabetta Soldaini; Rachel M McLoughlin; Stephen Rittenhouse; Fabio Bagnoli; Sanjay Phogat
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

3.  Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach.

Authors:  Tristan Ferry; Cécile Batailler; Sophie Brosset; Camille Kolenda; Sylvain Goutelle; Elliot Sappey-Marinier; Jérôme Josse; Frédéric Laurent; Sébastien Lustig
Journal:  SICOT J       Date:  2020-07-07

Review 4.  Bacteriophage therapy for bone and joint infections.

Authors:  Bryan P Gibb; Michael Hadjiargyrou
Journal:  Bone Joint J       Date:  2021-02       Impact factor: 5.082

5.  Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics.

Authors:  Xianghui Li; Tongxin Hu; Jiacun Wei; Yuhua He; Abualgasim Elgaili Abdalla; Guoying Wang; Yanzhang Li; Tieshan Teng
Journal:  Antibiotics (Basel)       Date:  2021-02-09

Review 6.  Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.

Authors:  Tristan Ferry; Camille Kolenda; Thomas Briot; Aubin Souche; Sébastien Lustig; Jérôme Josse; Cécile Batailler; Fabrice Pirot; Mathieu Medina; Gilles Leboucher; Frédéric Laurent
Journal:  Viruses       Date:  2021-12-02       Impact factor: 5.048

7.  What is the appropriate extended duration of antibiotic prophylaxis after two-stage revision for chronic PJI?

Authors:  Xinyu Fang; Qiaojie Wang; Xurong Yang; Feiyang Zhang; Changyu Huang; Zida Huang; Hao Shen; Wenming Zhang
Journal:  Bone Joint Res       Date:  2021-12       Impact factor: 4.410

8.  Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection.

Authors:  J-P Pirnay; G Resch; T Ferry; C Kolenda; F Laurent; G Leboucher; M Merabischvilli; S Djebara; C-A Gustave; T Perpoint; C Barrey
Journal:  Nat Commun       Date:  2022-07-22       Impact factor: 17.694

Review 9.  Bacteriophages: Combating Antimicrobial Resistance in Food-Borne Bacteria Prevalent in Agriculture.

Authors:  Arnold Au; Helen Lee; Terry Ye; Uday Dave; Azizur Rahman
Journal:  Microorganisms       Date:  2021-12-27

Review 10.  Considerations for the Use of Phage Therapy in Clinical Practice.

Authors:  Gina A Suh; Thomas P Lodise; Pranita D Tamma; Jane M Knisely; Jose Alexander; Saima Aslam; Karen D Barton; Erica Bizzell; Katherine M C Totten; Joseph L Campbell; Benjamin K Chan; Scott A Cunningham; Katherine E Goodman; Kerryl E Greenwood-Quaintance; Anthony D Harris; Shayla Hesse; Anthony Maresso; Veronique Nussenblatt; David Pride; Michael J Rybak; Zoe Sund; David van Duin; Daria Van Tyne; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.